Viagra side affects almost make sex sound

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
168
Viagra side affects almost make sex sound scary.

https://www.drugs.com/sfx/viagra-side-effects.html

Along with its needed effects, sildenafil (the active ingredient contained in Viagra) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking sildenafil:

Less common
Bladder pain
burning feeling in the chest or stomach
burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings
cloudy or bloody urine
dizziness
increased frequency of urination
indigestion
pain on urination
stomach upset
tenderness in the stomach area
Rare
Abnormal vision
anxiety
behavior change similar to drunkenness
bleeding of the eye
blurred vision
bone pain
breast enlargement
chest pain
chills
cold sweats
confusion
convulsions (seizures)
cool and pale skin
deafness or hearing loss
decrease in amount of urine or the frequency of urination
decreased vision
difficulty in concentrating
dizziness or lightheadedness, especially when getting up suddenly from a lying or sitting position
double vision
drowsiness
dry eyes
dry mouth
dryness, redness, scaling, or peeling of the skin
excessive hunger
eye pain
fainting or faintness
fast, irregular, or pounding heartbeat
feeling of something in the eye
fever or chills
headache (severe or continuing)
increase in the size of the pupil
increased sweating
increased thirst
lower back or side pain
migraine headache
nausea (severe or continuing)
nervousness
nightmares
numbness of the hands
painful, swollen joints
prolonged, painful erection of penis
redness, burning, or swelling of the eyes
redness, itching, or tearing of the eyes
restless sleep
seeing shades of colors differently than before
sensitivity to light
shakiness
skin lesions with swelling
skin paleness
skin rash, hives, or itching
skin ulcers
slurred speech
sore throat
sudden weakness
swelling of the face, hands, feet, or lower legs
trouble breathing
twitching of the muscles
unusual feeling of burning or stinging of the skin
unusual tiredness or weakness
vision changes
vision loss, temporary

Incidence not known
Blindness
Some side effects of sildenafil may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common
Aches or pains in the muscles
bloody nose
diarrhea
difficult or labored breathing
flushing
headache
pain or tenderness around the eyes and cheekbones
redness of the skin
sneezing
stomach discomfort following meals
stuffy or runny nose
trouble sleeping
unusually warm skin
Rare
Abdominal or stomach pain
abnormal dreams
anxiety
clumsiness or unsteadiness
cough
diarrhea or stomach cramps (severe or continuing)
difficulty in swallowing
ear pain
increased amount of saliva
increased skin sensitivity
lack of coordination
loss of bladder control
mental depression
nausea
numbness or tingling of the hands, legs, or feet
rectal bleeding
redness or irritation of the tongue
redness, soreness, swelling, or bleeding of the gums
ringing or buzzing in the ears
sensation of motion, usually whirling, either of one's self or of one's surroundings
sexual problems in men (continuing), including failure to experience a sexual orgasm
sleepiness
sores in the mouth and on the lips
tense muscles
trembling and shaking
vomiting
waking to urinate at night
worsening of asthma

For Healthcare Professionals
Applies to sildenafil: intravenous solution, oral suspension, oral tablet

General
The most common adverse reactions reported in clinical trials are headache, flushing, dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness, and rash.[Ref]

Cardiovascular
Very common (10% or more): Flushing (10%)
Uncommon (0.1% to 1%): Heart rate increased, palpitations, tachycardia, hypertension, hypotension
Rare (less than 0.1%): Myocardial infarction, atrial fibrillation, sudden cardiac death, ventricular arrhythmia, unstable angina
Frequency not reported: Ventricular arrhythmia, sudden cardiac death, angina pectoris, AV block, tachycardia, palpitation, hypotension, postural hypotension, myocardial ischemia, cerebral thrombosis, cardiac arrest, heart failure, abnormal electrocardiogram, cardiomyopathy, shock
Postmarketing reports: Serious cardiovascular, cerebrovascular, and vascular events, including myocardial infarction; sudden cardiac death; ventricular arrhythmia; cerebrovascular hemorrhage; transient ischemic attack; hypertension; subarachnoid, intracerebral, and pulmonary hemorrhage have been reported in temporal association with the use of this drug.[Ref]

Gastrointestinal
Very common (10% or more): Dyspepsia (up to 17%), diarrhea
Common (1% to 10%): Nausea, vomiting, dry mouth, gastritis, gastroesophageal reflux disease, hemorrhoids, abdominal distension
Rare (less than 0.1%): Oral hypoesthesia
Frequency not reported: Glossitis, colitis, dysphagia, gastroenteritis, esophagitis, stomatitis, gingivitis[Ref]

Musculoskeletal
Very common (10% or more): Pain in extremity
Common (1% to 10%): Back pain, myalgia
Frequency not reported: Arthritis, arthrosis, myalgia, tendon rupture, tenosynovitis, bone pain, myasthenia, synovitis[Ref]

Nervous system
Very common (10% or more): Headache (up to 28%)
Common (1% to 10%): Dizziness, migraine, tremor, paresthesia, burning sensation
Uncommon (0.1% to 1%): Somnolence, hypoesthesia
Rare (less than 0.1%): Cerebrovascular accident, syncope
Frequency not reported: Transient ischemic attack, seizure, seizure recurrence, ataxia, hypertonia, neuralgia, neuropathy, paresthesia, somnolence, reflexes decreased
Postmarketing reports: Transient global amnesia[Ref]

Ocular
Very common (10% or more): Abnormal vision (up to 11%)
Common (1% to 10%): Visual color distortion, retinal hemorrhage, visual impairment, vision blurred, photophobia, chromatopsia, cyanopsia, eye irritation, ocular hyperemia
Uncommon (0.1% to 1%): Conjunctival disorders, eye disorders, eye pain, lacrimation disorders, visual acuity reduced, diplopia, abnormal sensation in eye, photopsia, visual brightness, conjunctivitis
Rare (less than 0.1%): Retinal hemorrhage, arteriosclerotic retinopathy, retinal disorder, glaucoma, visual field defect, myopia, asthenopia, vitreous floaters, iris disorder, mydriasis, halo vision, eye edema, eye swelling, eyelid edema, scleral discoloration
Frequency not reported: Non-arteritic anterior ischemic optic neuropathy (NAION), retinal vascular occlusion, visual field defect, cataract[Ref]

This drug has lesser affinity for isoenzyme PDE6, an enzyme found in the retina. This lower selectivity is thought to be the basis for abnormalities related to color vision observed with higher doses or plasma levels.

Nonarteritic anterior ischemic optic neuropathy developed in one eye within minutes to hours after ingestion of sildenafil. Four of the five patients had no vascular risk factors for ischemic optic neuropathy.

-Abnormal Vision: Mild to moderate and transient, predominantly color tinge to vision, but also increased sensitivity to light, or blurred vision.
-Visual color distortions: Chloropsia, chromatopsia, cyanopsia, erythropsia and xanthopsia
-Lacrimation disorders: Dry eye, lacrimal disorder and lacrimation increased[Ref]

Respiratory
Very common (10% or more): Pharyngitis (18%), rhinitis
Common (1% to 10%): Nasal congestion, epistaxis, cough
Uncommon (0.1% to 1%): Sinus congestion
Rare (less than 0.1%): Throat tightness, nasal edema, nasal dryness
Frequency not reported: Asthma, dyspnea, laryngitis, pharyngitis, sinusitis, bronchitis, sputum increased, cough increased[Ref]

Dermatologic
Common (1% to 10%): Rash, alopecia, erythema, night sweats
Frequency not reported: Steven-Johnson syndrome (SJS), toxic epidermal necrolysis(TEN), urticaria, herpes simplex, pruritus, sweating, skin ulcer, contact dermatitis, exfoliative dermatitis[Ref]

Hematologic
Common (1% to 10%): Anemia
Frequency not reported: Leukopenia
Postmarketing reports: In patients with pulmonary arterial hypertension (secondary to sickle cell disease) taking Revatio (R), vaso-occlusive crises requiring hospitalization were more commonly reported. The clinical relevance of this finding in male patients treated with sildenafil (the active ingredient contained in Viagra) for erectile dysfunction is unknown.[Ref]

Metabolic
Common (1% to 10%): Fluid retention
Frequency not reported: Thirst, edema, gout, unstable diabetes, hyperglycemia, hyperuricemia, hypoglycemic reaction, hypernatremia[Ref]

Other
Common (1% to 10%): Cellulitis, influenza, bronchitis, sinusitis, rhinitis, gastroenteritis, vertigo, pyrexia
Uncommon (0.1% to 1%): Tinnitus, chest pain, fatigue, gynecomastia
Rare (less than 0.1%): Deafness, irritability
Frequency not reported: Sudden hearing loss, edema, face edema, peripheral edema, pain, chills accidental fall, accidental injury[Ref]

Psychiatric
Common (1% to 10%): Insomnia, anxiety
Frequency not reported: Abnormal dreams, depression[Ref]

Genitourinary
Uncommon (0.1% to 1%): Penile hemorrhage, hematospermia
Frequency not reported: Priapism, prolonged erection, increased erection, cystitis, nocturia, urinary frequency, urinary incontinence, abnormal ejaculation, genital edema, anorgasmia[Ref]

Renal
Uncommon (0.1% to 1%): Hematuria[Ref]

Hypersensitivity
Rare (less than 0.1%): Hypersensitivity reactions, including rash and urticaria[Ref]

Hepatic
Frequency not reported: Liver function tests abnormal[Ref]
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Viedoc and Bioforum Unite: Clinical Data Innovation

Updated Category News Views 24

Revamping Clinical Trials with Data Integration It doesn't take a Wall Street wizard to understand that in today's research game, having data is only half the battle—using it effectively is where the rubber meets the road. Enter Viedoc and Bioforum, two names that are well-acquainted with the grind of the clinical research world. These seasoned pros have joined forces,...

Continue Reading
Service Pros Adds Windshield Repair to Lineup

Updated Category News Views 27

Revving Up the Service Engine Alright, folks, buckle up because Service Pros Auto Glass, our local go-to for windshield replacements, is cranking up their game. They're stepping into the windshield repair arena across Florida and South Carolina, aiming to save you a buck and keep you safe behind the wheel. That's a double win if you ask me. A Closer Look at the Details...

Continue Reading
CNOOC Limited's 2026 Surge: New Projects, New Heights

Updated Category News Views 28

Production Peaks and New Discoveries Over in the bustling corridors of oil and gas, CNOOC Limited is making some strong waves. Why? Because they’ve hit historical peaks in production in the first three quarters of 2026. We’re talking about a net production of 593.7 million barrels of oil equivalent. That’s a 2.7% climb from last year. Seems like CNOOC is really...

Continue Reading
Ex-Guard Pushes Cost-Saving Grille Guards as Deer Season Hits

Updated Category News Views 77

Deer Season's Bumper Problem If you're driving a hefty pickup or van in the thick of deer season, forget looking at pretty autumn leaves. Instead, brace for the telltale thud—and the ensuing financial headache—that comes with a deer collision. Anyone who's tangled with such a mishap knows it's not just about the dent in your fender; it's about your wallet getting...

Continue Reading
Huawei's New O&M Strategies: A Game-Changer?

Updated Category News Views 15

Huawei's Latest O&M Revolution: What's on the Table? With Huawei dropping fresh O&M solutions at HUAWEI CONNECT 2026 in Shanghai, they're not just shaking things up—they're kicking the whole operation management game into hyperdrive using AI. They're zeroing in on the whole digital twin strategy, boasting some nifty pre-event, in-process, and post-event capabilities to...

Continue Reading
Bambusa Therapeutics: IPO Priced At $16, Shares On Nasdaq

Updated Category News Views 70

How Does Bambusa Therapeutics Stack Up? Well, here we go again in the biotech bonanza, folks. Bambusa Therapeutics is stepping onto the stage with their shiny new upsized IPO, offering a whopping 10,555,555 shares at sixteen bucks a pop. That's real money, coming in at $168,888,880 in gross proceeds if everything goes according to plan. Seems like a hefty sum, but in this...

Continue Reading
Sobi Names Börje Ekholm as Chair Amid New Data

Updated Category News Views 59

An Offbeat Choice for Chair? So, Sobi's gone and picked Börje Ekholm as the proposed Chair of their Board. Now, this might raise some eyebrows out there—Ekholm's no stranger to top roles, having steered the ship at Ericsson. The twist here is usually these Chair announcements hum along without much fanfare, but chuck in Ekholm and you get a bit of buzz—probably...

Continue Reading
Birth Injury Lawsuit Secures $19.1M Award in Michigan

Updated Category News Views 25

Legal Triumph for Sokolove's Birth Injury Case There are days when you see a win in the courtroom and think maybe, just maybe, justice ain't just a fairytale. Today, that thought knocks heavier with news rolling out of Michigan—an astronomical $19.1 million awarded to a family by a federal judge after a botched birth led to lifelong medical issues. You've got Sokolove...

Continue Reading
ACCULOAD: Aiming for Safer, Easier Boat Loading

Updated Category News Views 74

Getting a boat onto a trailer? It can turn into a circus act if you're not careful. Visibility's shot, conditions change faster than a stock ticker, and alignment's like threading a needle blindfolded. Out comes ACCULOAD, a novel idea created by some intrepid inventor down in Slocomb, Ala, aiming to solve what’s been a pain point for boaters worldwide. What's ACCULOAD...

Continue Reading
Foxconn Shakes Up EV Scene with New Models Unveiled

Updated Category News Views 29

Foxconn Boldly Claims New Ground in EV Market Foxconn's at it again, thumping its chest in the electric vehicle arena with three fresh rides that scream ambition. At the HHTD26 in Taipei, they rolled out the MODEL A+, MODEL K+, and MODEL K—vehicles that not only diversify their portfolio but target segments that rarely see such a jolt. Does it get your gears turning?...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Golub Capital BDC's Upcoming Earnings Report

Updated Category News Views 120

Understanding Golub Capital BDC's Earnings Expectations Golub Capital BDC (NASDAQ: GBDC) is on the brink of releasing its latest quarterly earnings report. Investors are keen to gauge the company's financial health and overall market performance. With anticipation growing, let’s delve into what to expect from this earnings announcement. Projected Earnings Performance...

Continue Reading
Bitcoin Cash Surges Over 10%: A Closer Look at Trends

Updated Category News Views 191

Bitcoin Cash Experiences Significant Surge In the last 24 hours, Bitcoin Cash has seen a remarkable price increase of 10.97%, now valued at $354.81. This impressive growth builds upon a positive trend observed over the previous week, during which the cryptocurrency gained 8.0%, rising from $328.29. Currently, it holds an all-time high at an astonishing $3,785.82,...

Continue Reading
AI Innovations Spark Concerns in Wealth Management Sector

Updated Category News Views 250

AI Innovations Disrupting Wealth Management Recent advancements in artificial intelligence have sent shockwaves through the wealth management sector. With the rollout of new AI capabilities by a leading fintech platform, investor worries about potential disruption have intensified. This week, we witnessed a considerable drop in wealth management and financial stocks as...

Continue Reading
Ibotta, Inc. Investors: Join the Class Action Opportunity

Updated Category News Views 154

Understanding the Class Action Lawsuit for Ibotta, Inc. The opportunity for investors of Ibotta, Inc. (NYSE: IBTA) to get involved in a class action lawsuit is significant. If you are among those who experienced substantial financial losses with Ibotta shares, this is a chance for you to take action. What Is the Class Action About? The class action lawsuit against Ibotta,...

Continue Reading
Vonage Launches Innovative RCS to Enhance Business Messaging

Updated Category News Views 68

Introducing Vonage RCS: The Future of Business Messaging Vonage is leading a transformative shift in business communications with their new Rich Communications Services (RCS). This innovative messaging platform aims to reshape how companies engage with customers by offering secure, interactive, and vibrant communication channels. A Fresh Take on Customer Interactions...

Continue Reading